CD8A and head and neck squamous cell carcinoma: However, the relatively low levels of B cells and PD-1+CD8+ cells in high-risk “Infiltrating” HPV− HNSCC suggest that ICI therapy may show a higher response if combined with treatments that reverse the lack of PD-1+CD8+ TILs in these patients.